Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thoracic transplantation in 1998

J V Conte1

  • 1Division of Cardiac Surgery, Johns Hopkins Hospital, USA.

Maryland Medical Journal (Baltimore, Md. : 1985)
|November 3, 1998
PubMed
Summary
This summary is machine-generated.

Thoracic transplantation, including heart, lung, and heart-lung transplants, is now a standard treatment for end-stage heart and lung disease. This review covers the current status and future directions of these life-saving procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery.

The Journal of cardiovascular surgery·2011
Same author

Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.

Journal of thrombosis and haemostasis : JTH·2009
Same author

Thoracic organ transplantation in the United States, 1995-2004.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Commentary on Cadaveric-donor organ recovery at a hospital-independent facility.

Transplantation·2002
Same author

Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2001
Same author

Lung transplantation for primary and secondary pulmonary hypertension.

The Annals of thoracic surgery·2001
Same journal

Adherence to the JNC VI guidelines for the treatment of hypertension in the resident clinic.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Seroprevalence study of Hantavirus infection in the community based population.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Pneumomediastinum: the Valsalva crunch.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Hepatic hydrothorax: diagnosis and management. Case report and review of the literature.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

A case of post-streptococcal reactive arthritis.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Sexual practices of older adults in a high HIV prevalence environment.

Maryland medical journal (Baltimore, Md. : 1985)·2000
See all related articles

Area of Science:

  • Cardiology
  • Pulmonology
  • Transplant Surgery

Background:

  • Thoracic transplantation has evolved significantly over the past 30 years.
  • It is now a well-established clinical option for patients with advanced heart and lung conditions.

Purpose of the Study:

  • To summarize the current state of heart, lung, and heart-lung transplantation.
  • To offer insights into the future advancements in the field.

Main Methods:

  • Review of current clinical practices and outcomes in thoracic transplantation.
  • Analysis of recent trends and future research directions.

Main Results:

  • Heart, lung, and combined heart-lung transplantations are no longer experimental.

Related Experiment Videos

  • These procedures are a standard treatment for selected patients with end-stage organ disease.

    • Conclusions:

    • Thoracic transplantation is a vital component of modern medicine for end-stage heart and lung disease.
    • The field continues to evolve, promising further improvements in patient care and outcomes.